Henry Hagopian III - Aug 29, 2022 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Chief Financial Officer
Signature
/s/ Henry Hagopian, III
Stock symbol
ANVS
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/31/2022, 08:14 PM
Next filing
Jan 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +120K $0.00 120K Aug 29, 2022 Common Stock 120K $11.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on August 29, 2023 and the remaining two-thirds will vest in eight consecutive quarterly installments beginning the fifteenth month after August 29, 2022, and will vest in full upon a Change of Control (as defined in the Company's 2019 Equity Incentive Plan), with vesting conditioned on continued employment on the applicable vesting dates.